HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideo Wada Selected Research

C-Type Lectins (C-Type Lectin)

1/2024Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.
12/2023Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299".
7/2023Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.
4/2023Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
1/2023Soluble C-type lectin-like receptor 2 in stroke (CLECSTRO) study: protocol of a multicentre, prospective cohort of a novel platelet activation marker in acute ischaemic stroke and transient ischaemic attack.
2/2022Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019.
7/2021Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction.
6/2021Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.
6/2019Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideo Wada Research Topics

Disease

86Disseminated Intravascular Coagulation
01/2024 - 03/2002
56Thrombosis (Thrombus)
01/2024 - 03/2002
26Neoplasms (Cancer)
03/2024 - 04/2002
25Infections
01/2023 - 06/2002
24Sepsis (Septicemia)
11/2023 - 06/2002
23Hemorrhage
03/2024 - 08/2002
19Thrombotic Thrombocytopenic Purpura
11/2023 - 05/2002
18Venous Thromboembolism
03/2024 - 01/2005
17Thrombocytopenia (Thrombopenia)
11/2023 - 01/2008
17Venous Thrombosis (Deep-Vein Thrombosis)
07/2021 - 08/2004
14Thrombotic Microangiopathies
04/2023 - 04/2005
13Thrombophilia
11/2023 - 04/2003
11Communicable Diseases (Infectious Diseases)
02/2021 - 04/2003
9Hemophilia A (Haemophilia)
09/2023 - 11/2017
9Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2021 - 08/2004
8Hemolytic-Uremic Syndrome
06/2019 - 05/2002
8Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2017 - 10/2003
7Atypical Hemolytic Uremic Syndrome
04/2023 - 05/2012
7Wounds and Injuries (Trauma)
04/2017 - 08/2002
7Pulmonary Embolism
10/2011 - 08/2004
5Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 08/2011
5COVID-19
05/2023 - 08/2021
5Critical Illness (Critically Ill)
03/2023 - 01/2005
5Connective Tissue Diseases (Connective Tissue Disease)
01/2019 - 12/2015
4Cerebral Infarction
03/2024 - 07/2021
4Hemolytic Anemia
11/2023 - 01/2017
4Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 04/2002
4Leukemia
01/2021 - 08/2002
4Lymphoma (Lymphomas)
01/2006 - 01/2003
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 11/2008
3Liver Diseases (Liver Disease)
01/2024 - 07/2005
3Inflammation (Inflammations)
02/2023 - 11/2005
3Colonic Neoplasms (Colon Cancer)
06/2022 - 01/2014
3Fibrosis (Cirrhosis)
06/2019 - 12/2004
3Neoplasm Metastasis (Metastasis)
01/2018 - 09/2002
3Heart Failure
01/2016 - 12/2004
3Aplastic Anemia (Anemia, Hypoplastic)
01/2006 - 07/2005
2Hepatocellular Carcinoma (Hepatoma)
01/2024 - 06/2010
2Bacterial Infections (Bacterial Infection)
04/2023 - 06/2009
2Myocardial Infarction
03/2023 - 07/2021
2Thromboembolism
03/2023 - 06/2010
2Shock
02/2023 - 08/2010

Drug/Important Bio-Agent (IBA)

87Dacarbazine (DIC)FDA LinkGeneric
01/2024 - 03/2002
29AntithrombinsIBA
11/2023 - 07/2002
28Hemostatics (Antihemorrhagics)IBA
01/2024 - 08/2002
27fibrin fragment D (D-dimer)IBA
03/2024 - 01/2003
26FibrinIBA
04/2023 - 03/2002
22Fibrinogen (Factor I)FDA Link
03/2023 - 03/2002
18thiamine triphosphorate (TTP)IBA
11/2023 - 05/2002
15ThrombomodulinIBA
01/2024 - 08/2002
13AnticoagulantsIBA
01/2024 - 01/2005
12Thromboplastin (Tissue Factor)IBA
01/2024 - 04/2002
12formycin diphosphate (FDP)IBA
03/2023 - 03/2002
11ThrombinFDA Link
09/2023 - 07/2002
9C-Type Lectins (C-Type Lectin)IBA
01/2024 - 06/2019
9von Willebrand FactorIBA
02/2023 - 01/2005
9Inosine Triphosphate (ITP)IBA
12/2021 - 08/2004
9Protein SIBA
10/2018 - 10/2003
8Protein CIBA
10/2018 - 01/2003
7Fibrin Fibrinogen Degradation ProductsIBA
01/2022 - 04/2003
7Messenger RNA (mRNA)IBA
01/2006 - 04/2003
6Biomarkers (Surrogate Marker)IBA
05/2023 - 01/2020
6Metalloproteases (Metalloproteinases)IBA
11/2014 - 10/2004
6ThrombospondinsIBA
11/2014 - 10/2004
6DisintegrinsIBA
11/2014 - 10/2004
5Complement System Proteins (Complement)IBA
04/2023 - 11/2014
5Proteins (Proteins, Gene)FDA Link
03/2017 - 10/2004
5Fondaparinux (Arixtra)FDA Link
05/2016 - 10/2011
5AntigensIBA
09/2015 - 07/2004
4emicizumabIBA
09/2023 - 11/2017
4Factor VIII (Coagulation Factor VIII)IBA
09/2023 - 01/2011
4eculizumabFDA Link
04/2023 - 04/2016
4DNA (Deoxyribonucleic Acid)IBA
06/2022 - 04/2005
4C-Reactive ProteinIBA
03/2020 - 07/2005
4Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 08/2004
4Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 06/2009
4antithrombin III-protease complexIBA
01/2013 - 08/2002
3Blood Coagulation Factors (Coagulation Factor)IBA
11/2023 - 01/2020
3BilirubinIBA
05/2023 - 11/2018
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2020 - 08/2004
3beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2019 - 09/2017
3AntibodiesIBA
10/2018 - 08/2004
3platelet membrane glycoprotein VIIBA
04/2017 - 03/2014
3Hemoglobins (Hemoglobin)IBA
01/2017 - 02/2012
3Antiphospholipid AntibodiesIBA
01/2016 - 01/2013
3Heparin (Liquaemin)FDA LinkGeneric
09/2014 - 05/2009
3CytokinesIBA
01/2013 - 01/2005
3fibrinmonomerIBA
09/2012 - 01/2003
3LipidsIBA
01/2005 - 07/2003
3Thomsen-Friedenreich antigenIBA
01/2005 - 07/2004

Therapy/Procedure

19Therapeutics
11/2023 - 04/2008
10Liver Transplantation
05/2023 - 08/2005
8Orthopedic Procedures
01/2021 - 02/2012
5Hepatectomy
01/2021 - 11/2008
4Renal Dialysis (Hemodialysis)
01/2022 - 01/2003
4Knee Replacement Arthroplasty (Total Knee Replacement)
01/2021 - 10/2011
4Drug Therapy (Chemotherapy)
05/2020 - 07/2005
4Splenectomy
03/2018 - 11/2008
3Hip Replacement Arthroplasty (Total Hip Replacement)
01/2021 - 10/2011
3Plasma Exchange
02/2013 - 05/2002